Millennium Management’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.24M Sell
210,378
-207,818
-50% -$3.76M ﹤0.01% 2885
2025
Q4
$4.84M Sell
418,196
-34,239
-8% -$325K ﹤0.01% 3053
2025
Q3
$3.93M Sell
452,435
-20,789
-4% -$177K ﹤0.01% 3383
2025
Q2
$3.38M Buy
473,224
+402,908
+573% +$3.29M ﹤0.01% 3383
2025
Q1
$457K Buy
70,316
+29,754
+73% +$469K ﹤0.01% 4870
2024
Q4
$746K Sell
40,562
-162,613
-80% -$4.96M ﹤0.01% 4430
2024
Q3
$7.03M Sell
203,175
-233,014
-53% -$9.13M ﹤0.01% 2528
2024
Q2
$12.8M Sell
436,189
-37,407
-8% -$1.48M 0.01% 1873
2024
Q1
$26.8M Buy
473,596
+320,009
+208% +$14.1M 0.01% 1295
2023
Q4
$6.59M Buy
153,587
+29,662
+24% +$941K ﹤0.01% 2551
2023
Q3
$4.3M Sell
123,925
-26,434
-18% -$1.15M ﹤0.01% 2833
2023
Q2
$6.99M Buy
150,359
+61,197
+69% +$3.05M ﹤0.01% 2356
2023
Q1
$4.12M Sell
89,162
-47,740
-35% -$3.03M ﹤0.01% 2778
2022
Q4
$11.1M Sell
136,902
-116,805
-46% -$8.12M 0.01% 2026
2022
Q3
$14.1M Buy
253,707
+23,028
+10% +$1.36M 0.01% 1731
2022
Q2
$12M Buy
230,679
+196,466
+574% +$11M 0.01% 1811
2022
Q1
$2.81M Buy
34,213
+19,649
+135% +$1.87M ﹤0.01% 3558
2021
Q4
$2.17M Sell
14,564
-6,894
-32% -$1.24M ﹤0.01% 3702
2021
Q3
$4.05M Sell
21,458
-26,354
-55% -$5.01M ﹤0.01% 3119
2021
Q2
$8.89M Sell
47,812
-7,868
-14% -$1.54M 0.01% 2060
2021
Q1
$12.7M Buy
55,680
+28,732
+107% +$6.82M 0.01% 1530
2020
Q4
$5.85M Sell
26,948
-4,973
-16% -$823K ﹤0.01% 2286
2020
Q3
$3.21K Buy
31,921
+13,506
+73% +$1.28M ﹤0.01% 2215
2020
Q2
$1.43M Buy
18,415
+15,767
+595% +$1.51M ﹤0.01% 2769
2020
Q1
$270K Sell
2,648
-682
-20% -$71.7K ﹤0.01% 3240
2019
Q4
$366K Buy
3,330
+726
+28% +$74.8K ﹤0.01% 3558
2019
Q3
$236K Buy
2,604
+743
+40% +$75K ﹤0.01% 3703
2019
Q2
$212K Sell
1,861
-1,905
-51% -$210K ﹤0.01% 3730
2019
Q1
$429K Buy
+3,766
New +$392K ﹤0.01% 3367
2018
Q4
Sell
-7,666
Closed -$1.15M 4154
2018
Q3
$1.15M Buy
+7,666
New +$1.16M ﹤0.01% 2796

Other funds holding STRO

Millennium Management's STRO Position: Q1 2026 in Review

Millennium Management reduced its Sutro Biopharma (STRO) stake by 50% in Q1 2026, selling an estimated $3.76M and leaving 210,378 shares worth $5.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2885.

Millennium Management first reported a position in STRO in Q3 2018 and has held it in 30 quarters since. The position peaked at $26.8M in Q1 2024. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

  • Millennium Management held 210,378 shares of Sutro Biopharma worth $5.24M as of Q1 2026.
  • Millennium Management sold 207,818 Sutro Biopharma shares in Q1 2026, an estimated $3.76M.
  • Sutro Biopharma made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2885 holding.
  • Millennium Management first reported a position in Sutro Biopharma in Q3 2018 and has held it in 30 quarters since.
  • Millennium Management's Sutro Biopharma position peaked at $26.8M in Q1 2024.
  • 78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.